Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVA II: Oral Iron Supplementation and Vaccine Response in Iron Deficient Kenyan Women
NCT05919472Completed
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferrous sulfate in iron deficiency anemia (IDA) (3 arms). Primary endpoints: Anti-spike (S1) immunoglobulin (IgG) and anti-receptor-binding domain (RBD) IgG concentrations against SARS-CoV-2 at Day 56, IgG concentration against meningococcal serogroups A, C, W, and Y at Day 56 and 1 more. Started Jul 2023; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05919472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919472.